LOG IN
SIGN UP
BRIEF-Supernus Pharma Announces Expiration Of Hart-Scott-Rodino Waiting Period For Adamas Pharma Tender Offer
reuters.com · 11/23/2021 13:35
Northland Capital Markets Downgrades Adamas Pharmaceuticals to Market Perform, Announces $8.5 Price Target
Northland Capital Markets analyst Carl Byrnes downgrades Adamas Pharmaceuticals (NASDAQ:ADMS) from Outperform to Market Perform and announces $8.5 price target.
Benzinga · 11/17/2021 12:41
Adamis Pharmaceuticals Shares Move Higher; Traders Circulate Event Page For VirginiaBio. BZ NOTE: Co To Present Wednesday, Nov. 17
https://www.vabio.org/event/use-of-tempol-as-an-antiviral-therapeutic-against-covid-19/
Benzinga · 11/16/2021 19:33
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP is Investigating the Following Companies - BCML, GWB, ABTX, ESBK, ADMS, ACBI
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
PR Newswire · 11/09/2021 18:12
Supernus Pharmaceuticals, inc (SUPN) Q3 2021 Earnings Call Transcript
Good afternoon, everyone, and thank you for joining us today for Supernus Pharmaceuticals' Third Quarter 2021 Financial Results Conference Call. On the call with me today are Supernus' Chief Executive Officer, Jack Khattar; and Chief Financial Officer, Ti...
Motley Fool · 11/04/2021 04:01
Supernus up 10% following 2021 earnings guidance boost, Q3 beat
Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) are up ~10% in after-hours trading after the company boosted its full-year earnings guidance and beat Q3 earnings estimates. Operating earnings for 2021 are now expected to
Seekingalpha · 11/03/2021 22:01
How Much Of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) Do Institutions Own?
If you want to know who really controls Adamas Pharmaceuticals, Inc. ( NASDAQ:ADMS ), then you'll have to look at the...
Simply Wall St. · 11/02/2021 10:26
Will Adamas Pharmaceuticals (ADMS) Report Negative Q3 Earnings? What You Should Know
Zacks.com · 10/28/2021 04:41
Webull offers kinds of Adamas Pharma stock information, including NASDAQ:ADMS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADMS stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading ADMS stock methods without spending real money on the virtual paper trading platform.